We are live on
!
Find out more
EIM
Essex Investment Management Portfolio holdings
AUM
$632M
1-Year Est. Return
95.36%
This Fund
S&P 500
This Quarter
Est. Return
+23.67%
1 Year Est. Return
+95.36%
3 Year Est. Return
+271.62%
5 Year Est. Return
+354.98%
10 Year Est. Return
+3,586.14%
AUM
$677M
AUM Growth
+$39.8M
(+6.3%)
Cap. Flow
-$63.7M
Cap. Flow
% of AUM
-9.41%
Top 10 Holdings %
Top 10 Hldgs %
17.86%
Holding
545
New
68
Increased
61
Reduced
248
Closed
65
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CGC
Canopy Growth
CGC
|
+$7.77M |
| 2 |
Tilray
TLRY
|
+$6.93M |
| 3 |
CRON
Cronos Group
CRON
|
+$5.16M |
| 4 |
Alibaba
BABA
|
+$4.71M |
| 5 |
EFOR
Everforth Inc
EFOR
|
+$4.32M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$10.1M |
| 2 |
Biogen
BIIB
|
+$7.22M |
| 3 |
Amazon
AMZN
|
+$6.34M |
| 4 |
Illumina
ILMN
|
+$6.02M |
| 5 |
Corcept Therapeutics
CORT
|
+$5.39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.63% |
| 2 | Healthcare | 20.59% |
| 3 | Industrials | 12.66% |
| 4 | Consumer Discretionary | 8.35% |
| 5 | Materials | 6.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OPNT
301
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
| $302K | 0.04% |
22,987
-26,950
| -54% | -$393K |
|
302
Core Molding Technologies
CMT
$233M
| $299K | 0.04% |
40,501
+3,479
| +9% | +$27.6K |
|
|
IDXG
303
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
| $297K | 0.04% |
37,161
+3,193
| +9% | +$30K |
|
|
EA
304
DELISTED
Electronic Arts
EA
| $295K | 0.04% |
2,907
-291
| -9% | -$27.6K |
|
305
Campbell Soup
CPB
$6.91B
| $293K | 0.04% |
7,674
| – | – |
|
306
Genpact
G
$5.66B
| $291K | 0.04% |
8,285
-341
| -4% | -$10.8K |
|
|
AKTS
307
DELISTED
Akoustis Technologies Inc
AKTS
| $291K | 0.04% |
+50,000
| New | +$328K |
|
308
Everest Group
EG
$14B
| $287K | 0.04% |
1,329
| – | – |
|
|
OBCI
309
DELISTED
Ocean Bio-Chem Inc
OBCI
| $283K | 0.04% |
82,908
+9,199
| +12% | +$33.4K |
|
310
Celcuity
CELC
$4.37B
| $279K | 0.04% |
12,734
-448
| -3% | -$9.82K |
|
311
Visteon
VC
$2.83B
| $279K | 0.04% |
4,143
-176
| -4% | -$13.2K |
|
312
Sea Limited
SE
$75.4B
| $278K | 0.04% |
11,812
-14,613
| -55% | -$256K |
|
313
Waste Management
WM
$90B
| $272K | 0.04% |
2,620
| – | – |
|
|
DYSL
314
DELISTED
Dynasil Corporation of America
DYSL
| $266K | 0.04% |
261,035
+28,995
| +12% | +$29.1K |
|
|
PYX
315
DELISTED
Pyxus International, Inc.
PYX
| $261K | 0.04% |
+10,939
| New | +$228K |
|
316
Range Resources
RRC
$9.27B
| $260K | 0.04% |
23,138
+5,523
| +31% | +$59.9K |
|
|
LNW
317
DELISTED
Light & Wonder
LNW
| $257K | 0.04% |
12,598
-13,534
| -52% | -$323K |
|
318
Applied Industrial Technologies
AIT
$13.1B
| $255K | 0.04% |
4,281
+537
| +14% | +$31.1K |
|
|
AVLR
319
DELISTED
Avalara, Inc.
AVLR
| $252K | 0.04% |
4,515
-8,943
| -66% | -$415K |
|
320
Cibus
CBUS
$148M
| $239K | 0.04% |
271
-114
| -30% | -$81.3K |
|
321
Quest Resource Holding
QRHC
$31.4M
| $237K | 0.04% |
143,795
+12,342
| +9% | +$19.4K |
|
322
Trane Technologies
TT
$106B
| $233K | 0.03% |
2,155
| – | – |
|
323
Usio Inc
USIO
$72.3M
| $233K | 0.03% |
88,772
-77,002
| -46% | -$208K |
|
324
Outfront Media
OUT
$5.31B
| $231K | 0.03% |
10,022
-4,472
| -31% | -$93.8K |
|
325
Duke Energy
DUK
$96.8B
| $230K | 0.03% |
2,550
| – | – |
|
Similar funds
BI
KCMH
SFM
VIM
AP
TTSTC
WCM
FTC
Essex Investment Management's Q1 2019 Portfolio in Review
As of Q1 2019, Essex Investment Management held 545 positions worth $677M, up 6.3% from $637M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Essex Investment Management withdrew a net $63.7M in Q1 2019, closing 65 positions and reducing 248 holdings. Its most notable exit was NVIDIA, an estimated $10.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Essex Investment Management opened a new position in Tilray worth $5.95M.
- Essex Investment Management's largest Q1 2019 buy was Tilray: 9,087 shares worth $5.95M.
- Essex Investment Management added most to Canopy Growth in Q1 2019, an estimated $7.77M increase.
- Essex Investment Management's biggest Q1 2019 reduction was Biogen, cutting an estimated $7.22M.
- Essex Investment Management fully exited NVIDIA in Q1 2019, selling an estimated $10.1M.
- Essex Investment Management's ten largest holdings make up 18% of its $677M portfolio in Q1 2019.
- Essex Investment Management opened 68 new positions and closed 65 in Q1 2019.
- Essex Investment Management's portfolio value rose 6.3% quarter-over-quarter to $677M.
Based on Essex Investment Management's 13F filing for Q1 2019, filed 15 May 2019.